Clinical Trial Update: Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating border zone stereotactic radiosurgery with bevacizumab in glioblastoma multiforme has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Ajay Niranjan | Conditions: Glioblastoma Multiforme, Glioblastoma - Category | Phase 2 | Status: COMPLETED | Results posted: 2019-04-25